Related Experiment Videos
[Limited surgery for bronchogenic carcinoma].
1Tohoku Welfare Pension Hospital, Sendai, Japan.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|August 24, 2001
Summary
Limited lung cancer surgeries like wedge resection and segmentectomy are increasingly used for non-small cell lung cancer (NSCLC). However, evidence from randomized trials is limited, impacting their evaluation as standard alternatives.
Area of Science:
- Thoracic surgery
- Surgical oncology
- Pulmonology
Context:
- Increasing trend in limited surgical procedures for non-small cell lung cancer (NSCLC).
- Focus on balancing tumor resection with postoperative quality of life.
- Limited randomized controlled trials (RCTs) available for these less invasive techniques.
Purpose:
- To review the current status of limited lung cancer surgery.
- To analyze recent literature and institutional experience regarding these procedures.
- To evaluate the role of limited resections in stage I NSCLC treatment.
Summary:
- Wedge resection, segmentectomy, and simple lobectomy are gaining traction for NSCLC.
- Thoracoscopic lobectomy for stage I lung cancer is also noted.
- These limited operations are not yet widely accepted as alternatives to standard surgery due to insufficient RCT data.
Impact:
- Highlights the need for more robust clinical trials to validate limited lung cancer surgeries.
- Informs surgeons and oncologists about the current evidence and limitations of these procedures.
- Contributes to the ongoing discussion on optimizing lung cancer treatment strategies.